Finding all BRCA pathogenic mutation carriers: best practice models

Identifying germline BRCA pathogenic mutations in patients with ovarian or breast cancer is a crucial component in the medical management of affected patients. Furthermore, the relatives of affected patients can be offered genetic testing. Relatives who test positive for a germline BRCA pathogenic m...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoogerbrugge, Nicoline, Jongmans, Marjolijn CJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141577/
https://www.ncbi.nlm.nih.gov/pubmed/27514840
http://dx.doi.org/10.1038/ejhg.2016.95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141577/
https://www.ncbi.nlm.nih.gov/pubmed/27514840
http://dx.doi.org/10.1038/ejhg.2016.95

Ejemplares similares